Latest Insider Transactions at Angiodynamics Inc (ANGO)
This section provides a real-time view of insider transactions for Angiodynamics Inc (ANGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANGIODYNAMICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANGIODYNAMICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+7.96%
|
-
|
|
Jul 20
2022
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,691
+11.35%
|
-
|
|
Jul 20
2022
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
4,402
+37.44%
|
-
|
|
Jul 20
2022
|
Richard C Rosenzweig SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,963
+19.03%
|
-
|
|
Jul 20
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,961
+8.25%
|
-
|
|
Jul 20
2022
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
3,705
+7.03%
|
-
|
|
Jul 20
2022
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+20.07%
|
-
|
|
Jul 20
2022
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+16.71%
|
-
|
|
Jul 20
2022
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+5.94%
|
-
|
|
Jul 20
2022
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+7.41%
|
-
|
|
Jul 20
2022
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+5.43%
|
-
|
|
Jul 20
2022
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+12.42%
|
-
|
|
Jul 20
2022
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+12.49%
|
-
|
|
Jul 15
2022
|
Wesley Johnson |
SELL
Payment of exercise price or tax liability
|
Direct |
4,505
-5.26%
|
$94,605
$21.32 P/Share
|
|
Jul 15
2022
|
Wesley Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,022
+6.56%
|
$90,330
$15.95 P/Share
|
|
Jul 15
2022
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,398
-13.34%
|
$260,358
$21.32 P/Share
|
|
Jul 15
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,758
+13.7%
|
$221,370
$15.95 P/Share
|
|
Jul 12
2022
|
Dennis S Meteny |
SELL
Payment of exercise price or tax liability
|
Direct |
4,798
-3.97%
|
$95,960
$20.02 P/Share
|
|
Jul 12
2022
|
Dennis S Meteny |
BUY
Exercise of conversion of derivative security
|
Direct |
6,022
+4.75%
|
$90,330
$15.95 P/Share
|
|
Jul 07
2022
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-4.64%
|
$24,460
$20.54 P/Share
|
|
Jul 07
2022
|
Dave Helsel SVP Global Operations and R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,480
+11.66%
|
-
|
|
Jul 07
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-3.09%
|
$21,560
$20.54 P/Share
|
|
Jul 07
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
3,104
+8.18%
|
-
|
|
Jul 07
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
919
-2.48%
|
$18,380
$20.54 P/Share
|
|
Jul 07
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
3,233
+8.01%
|
-
|
|
Jul 07
2022
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,509
-1.89%
|
$30,180
$20.54 P/Share
|
|
Jul 07
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,188
+4.99%
|
-
|
|
Jul 07
2022
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,574
-2.06%
|
$171,480
$20.54 P/Share
|
|
Jul 07
2022
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,123
+5.7%
|
-
|
|
Apr 28
2022
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
3,513
-13.31%
|
$77,286
$22.44 P/Share
|
|
Apr 20
2022
|
Howard W Donnelly |
BUY
Exercise of conversion of derivative security
|
Direct |
6,022
+5.44%
|
$90,330
$15.95 P/Share
|
|
Apr 12
2022
|
Wesley Johnson |
SELL
Open market or private sale
|
Direct |
1,299
-1.6%
|
$29,877
$23.26 P/Share
|
|
Apr 11
2022
|
Wesley Johnson |
SELL
Open market or private sale
|
Direct |
6,201
-7.19%
|
$142,623
$23.0 P/Share
|
|
Feb 03
2022
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
583
-0.77%
|
$11,660
$20.48 P/Share
|
|
Feb 01
2022
|
Richard C Rosenzweig SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-8.47%
|
$25,074
$21.31 P/Share
|
|
Jan 12
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+1.3%
|
$22,000
$22.64 P/Share
|
|
Jan 11
2022
|
James C Clemmer President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.5%
|
$220,000
$22.84 P/Share
|
|
Oct 31
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-2.06%
|
$27,637
$29.37 P/Share
|
|
Oct 20
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
3,494
-11.69%
|
$94,338
$27.97 P/Share
|
|
Oct 15
2021
|
Scott Centea SVP/GM, VIT |
SELL
Open market or private sale
|
Direct |
12,000
-20.6%
|
$324,000
$27.92 P/Share
|
|
Oct 15
2021
|
Scott Centea SVP/GM, VIT |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+17.08%
|
$192,000
$16.77 P/Share
|
|
Oct 05
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Open market or private sale
|
Direct |
10,748
-25.3%
|
$290,196
$27.15 P/Share
|
|
Oct 05
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
10,748
+20.19%
|
$171,968
$16.59 P/Share
|
|
Aug 12
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,231
-1.72%
|
$33,237
$27.29 P/Share
|
|
Aug 12
2021
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,231
+4.32%
|
-
|
|
Aug 12
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-2.42%
|
$18,954
$27.29 P/Share
|
|
Aug 12
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
2,395
+7.62%
|
-
|
|
Aug 12
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,021
-2.38%
|
$243,567
$27.29 P/Share
|
|
Aug 12
2021
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,387
+4.87%
|
-
|
|
Aug 12
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
788
-3.22%
|
$21,276
$27.29 P/Share
|